PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology, Stanford University, Palo Alto, California, USA.\', \'Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, California, USA.\', \'Unidos en Salud/United in Health, San Francisco, California, USA.\', \'California Department of Public Health, Microbial Diseases Laboratory, Richmond, California, USA.\', \'Division of Epidemiology and Biostatistics, University of California, Berkeley, California, USA.\', \'Department of Biochemistry and Biophysics, University of California San Francisco, CA, USA.\', \'Chan Zuckerberg Biohub, San Francisco, California, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/cid/ciaa1890
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33367619
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Field Performance and Public Health Response Using the BinaxNOWTM Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all